U.S. Pharmaceutical Industry Seen to Focus on COVID-19 Treatments Amid Competitive Environment
ArchIntel
JUNE 2, 2021
Companies are expected to be sustained by the revenues from therapies and vaccines to combat the coronavirus , which they managed to develop at unprecedented speeds. This fierce competition is predicted to propel the U.S. The recalcitrant COVID-19 pandemic is both the biggest source of risk and the bringer of opportunity to the U.S.
104 
Let's personalize your content